These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12748321)

  • 21. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
    Muller MP; Dresser L; Raboud J; McGeer A; Rea E; Richardson SE; Mazzulli T; Loeb M; Louie M;
    Pharmacotherapy; 2007 Apr; 27(4):494-503. PubMed ID: 17381375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of ribavirin and corticosteroids for severe acute respiratory syndrome.
    Lau EH; Cowling BJ; Muller MP; Ho LM; Tsang T; Lo SV; Louie M; Leung GM
    Am J Med; 2009 Dec; 122(12):1150.e11-21. PubMed ID: 19958895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticosteroids in acute lung injury and acute respiratory distress syndrome.
    Bauer SR; Lam SW; Heresi GA
    Crit Care Med; 2009 Sep; 37(9):2680-1; author reply 2681. PubMed ID: 19687659
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical diagnosis, treatment and prognosis of elderly SARS patients].
    Cao B; Liu ZY; Wang MZ; Cai BQ; Xu ZJ; Bai Y; Zhu YJ; Xu WB; Lu WX; Li LY; Li TS; Wang Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):547-9. PubMed ID: 14650155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids.
    Ward SE; Loutfy MR; Blatt LM; Siminovitch KA; Chen J; Hinek A; Wolff B; Pham DH; Deif H; LaMere EA; Kain KC; Farcas GA; Ferguson P; Latchford M; Levy G; Fung L; Dennis JW; Lai EK; Fish EN
    Antivir Ther; 2005; 10(2):263-75. PubMed ID: 15865221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Corticosteroids and non-steroidal anti-inflammatory agents in the treatment of acute respiratory distress syndrome and bacterial pneumonia].
    Chidiac C; Senneville E; Mouton Y
    Rev Prat; 1989 Apr; 39(12):1058-61. PubMed ID: 2662363
    [No Abstract]   [Full Text] [Related]  

  • 28. Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome.
    Chihrin S; Loutfy MR
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):251-62. PubMed ID: 15918782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic treatment of SARS: current knowledge and recommendations.
    Tai DY
    Ann Acad Med Singap; 2007 Jun; 36(6):438-43. PubMed ID: 17597972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ribavarin should be tested in clinical trials in combination with other antiviral agents for severe acute respiratory syndrome.
    Chu CM; Chan KS
    Chest; 2005 Dec; 128(6):4050. PubMed ID: 16354884
    [No Abstract]   [Full Text] [Related]  

  • 31. Response to published article, "The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study.".
    Chun-Wing Lau A; So LK; Yam LY; Chan KS
    J Infect; 2006 Apr; 52(4):309-10. PubMed ID: 16209889
    [No Abstract]   [Full Text] [Related]  

  • 32. Ribavirin in the treatment of SARS: A new trick for an old drug?
    Koren G; King S; Knowles S; Phillips E
    CMAJ; 2003 May; 168(10):1289-92. PubMed ID: 12743076
    [No Abstract]   [Full Text] [Related]  

  • 33. Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study.
    Li SS; Cheng CW; Fu CL; Chan YH; Lee MP; Chan JW; Yiu SF
    Circulation; 2003 Oct; 108(15):1798-803. PubMed ID: 14504188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerosolized ribavirin-induced reversible hepatotoxicity in a hematopoietic stem cell transplant recipient with Hodgkin lymphoma.
    Chaves J; Huen A; Bueso-Ramos C; Safdar A; Vadhan-Raj S
    Clin Infect Dis; 2006 Apr; 42(8):e72-5. PubMed ID: 16575720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers.
    Chiou HE; Liu CL; Buttrey MJ; Kuo HP; Liu HW; Kuo HT; Lu YT
    Chest; 2005 Jul; 128(1):263-72. PubMed ID: 16002945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy outcome after exposure to injectable ribavirin during embryogenesis.
    Rezvani M; Koren G
    Reprod Toxicol; 2006 Jan; 21(1):113-5. PubMed ID: 16122903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of severe acute respiratory syndrome.
    Hui DS; Sung JJ
    Chest; 2004 Sep; 126(3):670-4. PubMed ID: 15364739
    [No Abstract]   [Full Text] [Related]  

  • 38. [Corticosteroid therapy and changes in chest radiogram in five patients with severe acute respiratory syndrome].
    Zhang J; Yang X; Tan H; Zheng XW
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Jun; 15(6):346-8. PubMed ID: 12837166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
    Knowles SR; Phillips EJ; Dresser L; Matukas L
    Clin Infect Dis; 2003 Oct; 37(8):1139-42. PubMed ID: 14523782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003.
    Leong HN; Ang B; Earnest A; Teoh C; Xu W; Leo YS
    Trop Med Int Health; 2004 Aug; 9(8):923-7. PubMed ID: 15303999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.